Literature DB >> 9873872

Inhibitors occur more frequently in African-American and Latino haemophiliacs.

L M Aledort, D M Dimichele.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9873872     DOI： 10.1046/j.1365-2516.1998.0146c.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  23 in total

1.  Pharmacogenetics and the immunogenicity of protein therapeutics.

Authors:  Chen Yanover; Nisha Jain; Glenn Pierce; Tom E Howard; Zuben E Sauna
Journal:  Nat Biotechnol       Date:  2011-10-13       Impact factor: 54.908

2.  Game, set, match for factor VIII mismatch?

Authors:  Connie H Miller
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

3.  Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.

Authors:  Devi Gunasekera; Ruth A Ettinger; Shelley Nakaya Fletcher; Eddie A James; Maochang Liu; John C Barrett; Janice Withycombe; Dana C Matthews; Melinda S Epstein; Richard J Hughes; Kathleen P Pratt
Journal:  Blood       Date:  2015-01-23       Impact factor: 22.113

Review 4.  Haemophilia management: time to get personal?

Authors:  T E Howard; C Yanover; J Mahlangu; A Krause; K R Viel; C K Kasper; K P Pratt
Journal:  Haemophilia       Date:  2011-06-08       Impact factor: 4.287

5.  Men with severe hemophilia in the United States: birth cohort analysis of a large national database.

Authors:  Marshall A Mazepa; Paul E Monahan; Judith R Baker; Brenda K Riske; J Michael Soucie
Journal:  Blood       Date:  2016-03-16       Impact factor: 22.113

6.  A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

Authors:  J N Lozier; P S Rosenberg; J J Goedert; I Menashe
Journal:  Haemophilia       Date:  2011-03-01       Impact factor: 4.287

7.  The Epidemiology of FVIII Inhibitors in Indian Haemophilia A Patients.

Authors:  Patricia Pinto; Tejashree Shelar; Vidhya Nawadkar; Darshana Mirgal; Alfiya Mukaddam; Preethi Nair; Priyanka Kasatkar; Tejasvita Gaikwad; Shahnaz Ali; Anshul Jadli; Rucha Patil; Anita Parihar; Sharda Shanbhag; Bipin Kulkarni; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Indian J Hematol Blood Transfus       Date:  2014-02-05       Impact factor: 0.900

Review 8.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

Review 9.  Immune response to FVIII in hemophilia A: an overview of risk factors.

Authors:  Kanjaksha Ghosh; Shrimati Shetty
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

10.  Factor VIII inhibitors in hemophilia A: rationale and latest evidence.

Authors:  Char Witmer; Guy Young
Journal:  Ther Adv Hematol       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.